Literature DB >> 27091131

Methods to control for unmeasured confounding in pharmacoepidemiology: an overview.

Md Jamal Uddin1,2, Rolf H H Groenwold3, Mohammed Sanni Ali3, Anthonius de Boer4, Kit C B Roes3, Muhammad A B Chowdhury5, Olaf H Klungel4.   

Abstract

Background Unmeasured confounding is one of the principal problems in pharmacoepidemiologic studies. Several methods have been proposed to detect or control for unmeasured confounding either at the study design phase or the data analysis phase. Aim of the Review To provide an overview of commonly used methods to detect or control for unmeasured confounding and to provide recommendations for proper application in pharmacoepidemiology. Methods/Results Methods to control for unmeasured confounding in the design phase of a study are case only designs (e.g., case-crossover, case-time control, self-controlled case series) and the prior event rate ratio adjustment method. Methods that can be applied in the data analysis phase include, negative control method, perturbation variable method, instrumental variable methods, sensitivity analysis, and ecological analysis. A separate group of methods are those in which additional information on confounders is collected from a substudy. The latter group includes external adjustment, propensity score calibration, two-stage sampling, and multiple imputation. Conclusion As the performance and application of the methods to handle unmeasured confounding may differ across studies and across databases, we stress the importance of using both statistical evidence and substantial clinical knowledge for interpretation of the study results.

Keywords:  Observational studies; Pharmacoepidemiology; Residual confounding; Review; Statistical methods; Unmeasured confounding; Unobserved confounding

Mesh:

Year:  2016        PMID: 27091131     DOI: 10.1007/s11096-016-0299-0

Source DB:  PubMed          Journal:  Int J Clin Pharm


  72 in total

Review 1.  Methods to assess intended effects of drug treatment in observational studies are reviewed.

Authors:  Olaf H Klungel; Edwin P Martens; Bruce M Psaty; Diederik E Grobbee; Sean D Sullivan; Bruno H Ch Stricker; Hubert G M Leufkens; A de Boer
Journal:  J Clin Epidemiol       Date:  2004-12       Impact factor: 6.437

2.  Evidence of bias in estimates of influenza vaccine effectiveness in seniors.

Authors:  Lisa A Jackson; Michael L Jackson; Jennifer C Nelson; Kathleen M Neuzil; Noel S Weiss
Journal:  Int J Epidemiol       Date:  2005-12-20       Impact factor: 7.196

3.  Prior event rate ratio adjustment: numerical studies of a statistical method to address unrecognized confounding in observational studies.

Authors:  Menggang Yu; Dawei Xie; Xingmei Wang; Mark G Weiner; Richard L Tannen
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-05       Impact factor: 2.890

4.  Bias formulas for sensitivity analysis of unmeasured confounding for general outcomes, treatments, and confounders.

Authors:  Tyler J Vanderweele; Onyebuchi A Arah
Journal:  Epidemiology       Date:  2011-01       Impact factor: 4.822

Review 5.  Ecologic studies in epidemiology: concepts, principles, and methods.

Authors:  H Morgenstern
Journal:  Annu Rev Public Health       Date:  1995       Impact factor: 21.981

6.  Current problems and future challenges in randomized clinical trials.

Authors:  A R Feinstein
Journal:  Circulation       Date:  1984-11       Impact factor: 29.690

7.  Case-crossover and case-time-control designs in birth defects epidemiology.

Authors:  Sonia Hernández-Díaz; Miguel A Hernán; Katie Meyer; Martha M Werler; Allen A Mitchell
Journal:  Am J Epidemiol       Date:  2003-08-15       Impact factor: 4.897

8.  Propensity score calibration in the absence of surrogacy.

Authors:  Mark Lunt; Robert J Glynn; Kenneth J Rothman; Jerry Avorn; Til Stürmer
Journal:  Am J Epidemiol       Date:  2012-04-24       Impact factor: 4.897

9.  Performance of prior event rate ratio adjustment method in pharmacoepidemiology: a simulation study.

Authors:  Md Jamal Uddin; Rolf H H Groenwold; Tjeerd P van Staa; Anthonius de Boer; Svetlana V Belitser; Arno W Hoes; Kit C B Roes; Olaf H Klungel
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-11-20       Impact factor: 2.890

Review 10.  Case-only designs in pharmacoepidemiology: a systematic review.

Authors:  Sandra Nordmann; Lucie Biard; Philippe Ravaud; Marina Esposito-Farèse; Florence Tubach
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

View more
  24 in total

1.  Association of Oral Anticoagulants and Proton Pump Inhibitor Cotherapy With Hospitalization for Upper Gastrointestinal Tract Bleeding.

Authors:  Wayne A Ray; Cecilia P Chung; Katherine T Murray; Walter E Smalley; James R Daugherty; William D Dupont; C Michael Stein
Journal:  JAMA       Date:  2018-12-04       Impact factor: 56.272

2.  Instrumental variable analysis in the presence of unmeasured confounding.

Authors:  Zhongheng Zhang; Md Jamal Uddin; Jing Cheng; Tao Huang
Journal:  Ann Transl Med       Date:  2018-05

3.  The emerging landscape of health research based on biobanks linked to electronic health records: Existing resources, statistical challenges, and potential opportunities.

Authors:  Lauren J Beesley; Maxwell Salvatore; Lars G Fritsche; Anita Pandit; Arvind Rao; Chad Brummett; Cristen J Willer; Lynda D Lisabeth; Bhramar Mukherjee
Journal:  Stat Med       Date:  2019-12-20       Impact factor: 2.373

4.  External adjustment of unmeasured confounders in a case-control study of benzodiazepine use and cancer risk.

Authors:  Lau Caspar Thygesen; Anton Pottegård; Annette Kjaer Ersbøll; Søren Friis; Til Stürmer; Jesper Hallas
Journal:  Br J Clin Pharmacol       Date:  2017-07-12       Impact factor: 4.335

5.  Primary Tumor Resection is Associated with Improved Disease-Specific Mortality in Patients with Stage IV Small Intestinal Neuroendocrine Tumors (NETs): A Comparison of Upfront Surgical Resection Versus a Watch and Wait Strategy in Two Specialist NET Centers.

Authors:  Koert F D Kuhlmann; Margot E T Tesselaar; Sonja Levy; James D Arthur; Melissa Banks; Niels F M Kok; Stephen W Fenwick; Rafael Diaz-Nieto; Monique E van Leerdam; Daniel J Cuthbertson; Gerlof D Valk
Journal:  Ann Surg Oncol       Date:  2022-07-16       Impact factor: 4.339

Review 6.  Transgenerational and intergenerational epigenetic inheritance in allergic diseases.

Authors:  Toril Mørkve Knudsen; Faisal I Rezwan; Yu Jiang; Wilfried Karmaus; Cecilie Svanes; John W Holloway
Journal:  J Allergy Clin Immunol       Date:  2018-07-21       Impact factor: 10.793

Review 7.  Best Practices in Large Database Clinical Epidemiology Research in Hepatology: Barriers and Opportunities.

Authors:  Nadim Mahmud; David S Goldberg; Therese Bittermann
Journal:  Liver Transpl       Date:  2021-08-07       Impact factor: 5.799

8.  Vaccine Effectiveness Against Influenza-Associated Hospitalizations Among Adults, 2018-2019, US Hospitalized Adult Influenza Vaccine Effectiveness Network.

Authors:  Jill M Ferdinands; Manjusha Gaglani; Shekhar Ghamande; Emily T Martin; Donald Middleton; Arnold S Monto; Fernanda Silveira; Helen K Talbot; Richard Zimmerman; Emily R Smith; Manish Patel
Journal:  J Infect Dis       Date:  2021-07-02       Impact factor: 5.226

Review 9.  Adjusting for unmeasured confounding in nonrandomized longitudinal studies: a methodological review.

Authors:  Adam J Streeter; Nan Xuan Lin; Louise Crathorne; Marcela Haasova; Christopher Hyde; David Melzer; William E Henley
Journal:  J Clin Epidemiol       Date:  2017-04-28       Impact factor: 6.437

10.  A comparison of estimators from self-controlled case series, case-crossover design, and sequence symmetry analysis for pharmacoepidemiological studies.

Authors:  Yoshinori Takeuchi; Tomohiro Shinozaki; Yutaka Matsuyama
Journal:  BMC Med Res Methodol       Date:  2018-01-08       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.